Dexcom (DXCM) appoints Jereme Sylvain as EVP, COO & CFO; company discloses new compensation. Investor implications for operations and finance.
Dexcom (DXCM) names Glenn S. Boehnlein an independent director and grants equity. Read investor-focused analysis, governance context and key risks. 2026-09-10.